I had said before that $Moderna (MRNA.US)$ wasnt quite as sm...
I had said before that $Moderna(MRNA.US$ wasnt quite as smart as $Pfizer(PFE.US$ or $AstraZeneca(AZN.US$ in how they apprached clinical strategy but this is telling - mRNA is mRNA, and granted that things like the lipid shell might and solution might be a significant enough variable in certain populations, but this is a great study. Well planned, good execution - finally Moderna having control over the clinical narrative, expect more of this and so more confidence by analysts
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Interested mainly in life sciences / healthcare, but also a few stocks where I can see the company in action around me
19Followers
8Following
34Visitors
Follow
Tran.Dong : Still bearish :((